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Introduction
Gene therapy involves the administration of exogenous, therapeutic nucleic acids to enable the treatment of a disease (Pushpendra et al., 2012) . The delivery of nucleic acids is largely agreed to be the rate limiting step to the introduction of new gene therapies (Couzin-Frankel, 2009; Guo and Huang, 2012) and despite the enormous investment in the science of gene therapy, only two approved products are available -Gendicine (Peng, 2005) and Glybera (Miller, 2012) ; both of which utilise viral vectors. There are no approved gene or ribonucleic acid [RNA -small interfering RNA (siRNA) or messenger RNA (mRNA)] therapeutics facilitated by synthetic vectors, although some synthetic lipid (Hyde et al., 2000) and poly(ethylenimine) (Gofrit et al., 2014) vectors have been tested in humans. For genes or RNA to be effective they require to be delivered intact to the inside of cells (Liang and Lam, 2012) and specifically the cell nucleus in the case of DNA (Scholz and Wagner, 2012) ; avoiding blood components, immune defence mechanisms, and enzymatic degradation (Scholz and Wagner, 2012 ).
Cationic polymers, in which the polymers have multiple amine groups, have been used to deliver therapeutic nucleic acids, as they form nanoparticle electrostatic complexes with nucleic acids at physiological pH (Brownlie et al., 2004) . However cationic polymers are cytotoxic to cells, e.g. with IC50 values of 0.0019 -0.0036 mg mL -1 in the case of branched poly(ethylenimine) (PEI) (Brownlie et al., 2004; Cheng et al., 2006) and 0.074 mg mL -1 in the case of linear PEI (Kafil and Omidi, 2011) . This poor biocompatibility is presumably one of the reasons why linear PEI, when trialed in humans, was applied directly into the bladder (Gofrit et al., 2014) . This local administration is similar to the way that the viral gene therapy products are used, i.e. intratumourally in the case of Gendicine or intramuscular (30 -70 individual injections) in the case of Glybera (Gaudet et al., 2010; Peng, 2005) .
The ultimate aim of our work is to develop nucleic acid medicines, which are active against central nervous system (CNS) diseases. In order to overcome the limitations to delivery posed by the blood brain barrier (Lalatsa et al., 2011) , the intranasal route has been advocated. This route is emerging as an important route for the delivery of macromolecules to the brain via the olfactory bulb (Chapman et al., 2013) . Thus, despite studies reporting the intracranial delivery of PEI -gene complexes (Boussif et al., 1995) , the cytotoxicity of cationic polymers such as PEI means that they are not suitable for therapeutics intended for nose to brain delivery and a different type of carrier is required; one that is less intrinsically toxic to the neuronal tissue.
The development of such a carrier is our goal.
Chitosan and its derivatives have been used as nucleic acid delivery systems ; Uchegbu et al., 2004) . Chitosan, which is composed of glucosamine and Nacetylglucosamine monomers linked by (1,4)-glycosidic bonds, is less cytotoxic when compared to delivery systems such as PEI (Kean and Thanou, 2010 ) (Alves and Mano, 2008) .
However, at physiological pH (pH = 7.4), chitosan based nucleic acid delivery systems are generally less efficient than the polyamine (Erbacher et al., 1998; Hoggard-Koping et al., 2001; Moreira et al., 2009) or cationic lipid (Leong et al., 1998) carriers.
The transfection efficiency of chitosan is dependent on the pH of the environment, as protonation of the primary amines must occur prior to complexation of chitosan with the phosphate groups of DNA. Chitosan (pKa of 6.2 -6.5 (Wang et al., 2006) ) behaves as an acid at physiological pH , is insoluble and shows low transfection ability (Lavertu et al., 2006; Nimesh et al., 2010) . As the level of acetylation increases chitosan's transfection efficacy decreases (Huang et al., 2005) . This is not unexpected as acetylation decreases the aqueous solubility of chitosan. The molecular weight of chitosan is another characteristic of the polymer that appears to affect the transfection efficiency. Some reports claim that a molecular weight range of 100 -400 kDa (along with a low degree of acetylation) results in optimum transfection efficiency (Huang et al., 2005; Techaarpornkul et al., 2010) , while other reports state that a molecular weight of less than 100 kDa is optimum for nucleic acid transfer (Erbacher et al., 1998; Hoggard-Koping et al., 2001; Holzerny et al., 2012; Techaarpornkul et al., 2010; Uchegbu et al., 2004) .
Various derivatives of chitosan have been synthesized to address the low DNA binding capacity of chitosan at physiological pH and as such trimethyl quaternary ammonium (Thanou et al., 2002) , histidine (Moreira et al., 2009) , urocanic acid (Kim et al., 2003) and PEI (Tripathi et al., 2012) chitosan derivatives have been evaluated. While these strategies do increase the transfection efficiency of chitosan, some of these new nucleic acid carriers were shown to be relatively cytotoxic (e.g. IC50 = 0.09 mg mL -1 ) (Wong et al., 2006) , or their ultimate in vitro gene transfer efficiency was still significantly inferior to the commercial transfection agentLipofectamine (Kim et al., 2003) .
To utilise the nose to brain route, it is important to prepare efficient nucleic acid vectors with low cell cytotoxicity as vectors. siRNA nose to brain delivery has been attempted with both naked siRNA (Renner et al., 2012) and with siRNA complexed with various carriers (Kim et al., 2012; Perez et al., 2012) . While most of the carriers were not evaluated for their cytotoxicity, some of the carriers, which were tested for their cytotoxicity, were toxic to cells in vitro at a concentration of 0.08 mg mL -1 .
In this work we have prepared various N-(2-ethylamino)-6-O-glycolchitosan polymers. The ethylamine groups were added to enable the polymer to be protonated at physiological pH and bind to the anionic phosphate groups of DNA, siRNA and mRNA. We have ascertained the level of ethylamine substitution which provides good nucleic acid transfer as well as low cytotoxicity. The 6-O-glycol unit increases the water solubility of the polymer at physiological pH when compared to chitosan (Chooi et al., 2014; Uchegbu et al., 2014a) ; polymer water solubility will contribute to nucleic acid binding as insoluble material will not be available to bind the solution phase nucleic acids. In considering the design of our vector, we opted for a molecular weight of between 10 -30 kDa, as previously chitosan N-trimethyl derivatives were more active as gene transfer systems in this molecular weight range ).
Experimental Section

Materials
All chemicals and reagents were supplied by Sigma Aldrich, Dorset, UK, unless otherwise specified. Organic solvents were supplied by Fischer Scientific, Dorset, UK and Visking seamless cellulose dialysis membranes were obtained from Medicell International Ltd., London, UK. All chemicals and reagents were used without further purification. Tissue culture reagents were obtained from Invitrogen, Paisley, UK.
Synthesis and Characterisation of N-(2-ethylamino)-6-O-glycolchitosan
Glycol chitosan (GC) was degraded in hydrochloric acid (HCl) as previously described (Siew et al., 2012) . Briefly (GC, 1g, 4.9 mmoles of monomer) was dissolved in hydrochloric acid (4M, 76 mL) and placed for 4 hours in a preheated water bath at 50ºC. The product resulting from the acid degradation (GC28) was purified by dialysis (Visking seamless cellulose tubing, molecular weight cut off 7000 Da) against deionised water (5L) with six changes over 24 hours.
The dialysed solution was freeze-dried and purified GC28 was recovered as a cream coloured GC25 and GC24 were synthesised in a similar manner to GC28 except that the GC, HCL ratio was increased. (GC, 2.00 g, 9.8 mmoles of monomer) was dissolved in hydrochloric acid (4 M, 38 mL) and placed for 4 hours and 5 hours respectively in a preheated water bath at 50 ºC to get GC25 and GC24. The products resulting from the acid degradation (GC25 and GC24)
were purified by dialysis (Visking seamless cellulose tubing, molecular weight cut off 3,500
Da) against deionised water (5 L) with six changes over 24 hours. The dialysed solutions were freeze-dried and low molecular weight GC (GC25 and GC24) were recovered as a cream coloured cotton wool like material A further batch of GC (GC17) with an even lower molecular weight was synthesised in a similar manner to GC28 except that the incubation in HCL was carried out for 8 hours: Yield = 0.5 g. The degraded GC (GC28, 100 mg, 0.49 mmoles of monomer) was dissolved in a solution of N-methyl-2-pyrrolidone (NMP) (20 mL) containing triethylamine (500µL, 3.59 mmoles). The solution was allowed to stir for 1h at 40ºC in an oil bath until the GC was completely dissolved.
To this dissolved GC was added 2-tertbutoxycarbonylamino-ethyl bromide (1000 mg, 4.46 mmoles) such that the molar ratio between GC monomer and 2-tertbutoxycarbonylamino-ethyl bromide was 1: 10. The reaction was left to stir for 24h, at 40ºC. Finally the solution was mixed with water (40 mL) and washed with diethyl ether (3 x 50 mL) to remove the unreacted 2-tertbutoxycarbonylamino-ethyl bromide. The aqueous phase was collected and dialyzed, as previously described, against deionised water (5L) with six changes over 24 hours. The final polymer solution was freeze-dried. The recovered polymer was dissolved in HCL (50 ml, 4M) and stirred for 3 hours at room temperature in order to cleave the tertbutoxycarbonyl group.
This solution was dialyzed as previously described and freeze dried to give N-(2-ethylamino)- 
Gel Permeation Chromatography -Multi-angle Laser Light Scattering (GPC-
MALLS)
The molecular weight of the GC and EAGC polymers were determined by GPC-MALLS.
Filtered samples (5 mg mL -1 ) were injected onto a POLYSEP-GFC-P guard column (35 x 7.8 mm, Phenomenex, UK) attached to a POLYSEP-GFC-P 4000 column using an Agilent 1200 substituted glycol chitosan (δ = 2.5 and 2.7 respectively) with the sugar methine and methylene protons (δ = 3.5 -4.1).
Titration
GC and EAGC hydrochloride salts [prepared by adjusting the pH of the initial solutions in water to pH = 2 with HCL (0.1M)] at a concentration of 2 mg mL -1 were titrated with NaOH (0.05M).
Under continuous stirring, the titrant was added drop wise. During the titration, the volume of NaOH added and pH values of polymer solutions were recorded using a MPT-2 Autotitrator, (Malvern Instruments, Malvern, UK).
The buffer capacity (C) is defined as the percentage of amino groups that become protonated in the pH range 5.1 to 7.4, and may be calculated using equation 1:
where V = volume of sodium hydroxide used to raise the pH to 7.4, M = number of moles of sodium hydroxide per L, N = number of protonable nitrogen atoms contained in the known amount of EAGC or GC being titrated (Lin et al., 2008 The power supply (PowerPac™, Bio Rad, Hemel, UK) was connected to the chamber and power applied for 1 h at 60 V or 30 min. at 100V for mRNA. The results were imaged on a UV Transilluminator (ChemiDoc™ MP System, Bio Rad, Hemel, UK) to visualise the ethidium bromide-stained DNA, mRNA or siRNA in the gels.
Transmission Electron Microscopy (TEM)
One drop of the EAGC -nucleic acid complexes (siRNA or DNA complexes prepared as previously described and incubated for 1h) was placed onto a carbon/ Formvar coated 200 mesh copper grid (Agar Scientific, Stansted, UK) and negatively stained with uranyl acetate solution (1% w/v). Polymer and naked nucleic acid solutions were imaged as negative controls. Imaging was carried out with a Philips CM120 Biotwin Transmission Electron Microscope (Philips, Eindhoven, The Netherlands). Digital images were captured using a 5MP
AMT camera (Deben UK Ltd, Suffolk, UK).
Size and Zeta Potential
The size of the complexes was determined by nanoparticle tracking analysis (NanoSight LM20, NanoSight Limited, Malvern, UK). The samples were prepared as previously described and allowed to incubate at room temperature for 1h. A volume of the sample (0.2 mL) was injected into the sample chamber. Videos of 30s in length were made and repeated 3 times with 0.2 mL of the sample being injected each time. The camera settings for the instrument were set using the 'Autosettings' option on the software. The focus used was judged by eye, and was adjusted so that the majority of particles seen were in focus at any one time. The minimum expected particle size was set at 30 nm for all samples and the minimum track length set to automatic. The particle size distribution was measured three times. The software calculated the mean (the average particle size measured), mode (the most frequent particle size found) and standard deviation (the breadth of the log-normal distribution fitted to the data).
In addition, each value is reported with its standard error. In this work the size is presented as mean values ± standard error and standard deviation of the size distribution ± standard error.
The particle size of mRNA polyplexes was measured using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) and the data analysed by CONTIN method of analysis. Sizing was carried out at room temperature.
The zeta potential of the dispersion was measured using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). The samples were prepared as previously described and incubated for 1h at room temperature. A disposable folded capillary cell (0.5 mL) was used for zeta potential measurements. Zeta potential is presented as the average of three measurements ± standard deviation.
2.4
In Vitro Biological Characterisation of the Nucleic Acid Complexes
Heparin
EAGC -nucleic acid complexes (0.1 mg mL -1 siRNA or DNA, 10 μL) were prepared as previously described and incubated for 1h at room temperature. Heparin (0.1 mg mL -1 or 1 mg mL -1 , 1 μL) was added to the complex dispersions and the dispersions incubated for 15 min. Samples were subjected to gel electrophoresis (TAE buffer) for 1 h at 60 V in order to investigate the stability of the binding complex in the presence of heparin. The results were imaged as described above.
Nuclease
Resistance to nuclease digestion was determined using a deoxyribonuclease (DNase) and ribonuclease (RNase) protection assay. EAGC -nucleic acid (siRNA or DNA) complexes (0.1 mg mL -1 siRNA or DNA, 10 μL) were prepared as previously described and incubated for 1h at room temperature. DNase or RNase (1 unit μL -1 , 1 μL) was added to the complex or to naked DNA or siRNA. The samples were incubated at 37 °C for 15 min. Immediately following incubation, all samples were treated with ethylene diamine tetraacetic acid (50 mM, 10 μL) for 10 min to deactivate the DNase and RNase. Finally, heparin (20 mg mL -1 , 1 μL) was added and the mixture was incubated for 30 min at room temperature to dissociate the complex and thus examine the integrity of the nucleic acids. Samples were subjected to gel electrophoresis (with TAE buffer) for 1 h at 60 V to investigate the stability of the complex against enzymatic degradation. The results were imaged as described above.
MTT Assay
The MTT reagent [3] [4] , 100 μL, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) added. Cells were incubated with the MTT solution for 2 h at 37°C, after which medium was removed, and dimethyl sulfoxide (DMSO, 100 μL) was added to each well to ensure complete solubilisation of the resulting formazan crystals. After incubation with DMSO for 10min at 37°C, the absorbance at 570 nm was measured using an ELx808 microplate reader (Bio-tek instruments, Potton, UK). For analysis, background values were subtracted. The cytotoxicity was determined as the ratio between the measured absorbance values of treated and untreated cells. Lysed cells (with Triton X-100, 21.4 mg mL-1, 100 μL per well) were used as a negative control (= 100% cell death).
The IC50 values (concentration of polymer at which 50% of cells are viable) were determined by analyses of the data using Prism4 software (GraphPad Software, Inc. La Jolla, USA). The sigmoidal dose response curve was analysed with Rmax fixed at 100 and Rmin at 0.
Cytotoxicity results are presented as the average of three measurements ± standard deviation.
2.5
In Vitro Gene Transfection
General Method
Briefly, 96-well plates were seeded with 10,000 cells (A431) per well and incubated overnight.
The complexes were prepared to a final DNA concentration of 0.1 mg mL The complexes were then replaced with fresh MEM. The cells were replenished with fresh MEM daily and the cells incubated for a further 48 h.
Transfection with Chloroquine
Transfection experiments were carried out using chloroquine to investigate the stability of polyplexes in the endosome, following endosomal uptake of the polyplexes. All experiments were carried out as detailed above, except that the cells were incubated with cell medium containing 100μM chloroquine along with the polyplexes. The cells were transfected for 4 hours before the medium was changed.
In vitro siRNA Transfection
Briefly, 6-well plates were seeded with 500,000 cells (A431 cells) per well and incubated overnight. The complexes were prepared to a final ITCH siRNA/ scrambled siRNA (Eurofins mwg/operon, London, UK) concentration of 0.014 mg mL -1
. Polymer stock solutions (EAGC29)
were prepared in sterile dextrose (5% w/v) and filtered with a 0.22 μm Millex filter. To the polymer solutions were added equal volumes of the ITCH siRNA/ scrambled siRNA stock solutions (in insiMAX universal buffer) to give formulations at a range of EAGC29, siRNA weight ratios. The complexes were allowed to incubate at room temperature for 1 hour, after which the EAGC29 -siRNA complexes were added to the cells (0.014 mg mL -1 siRNA, 750μL, ChemiDoc™ XRS+ System (Bio Rad, Hemel, UK). For each membrane, the analysis of band intensity was performed using Image Lab software (BioRad, Hemel, UK).
In vitro mRNA transfection
Briefly, 6-well plates were seeded with 500,000 cells (A431 cell line) per well and incubated overnight. The complexes were prepared to a final mRNA concentration of 5 g mL 
2.6
In vivo administration of siRNA Sprague Dawley rats (200-250 g) were housed four per cage in an air-conditioned unit maintained at 20 -22°C and 50 -60 % relative humidity, and were allowed free access to standard rodent chow and water. Lighting was controlled on a twelve-hour cycle (lights on at 07.00 h and lights off at 19.00 h). Animals were habituated for 7 days prior to experimentation and acclimatised to the procedure room for 1h prior to testing at 08.00 h. All protocols were conducted under a UK Home Office licence, in accordance with the Animals Scientific
Procedures Act 1986 and approved by a local ethical committee.
Rats ( and an EAGC29, siRNA polyplex formulation at an EAGC29, siRNA weight ratio of 60: 1 (40μL per nare, 15 μg of siRNA, BLOCK-iT™ Alexa Fluor® Red Fluorescent Control). Animals were briefly anesthetised with isoflurane and intranasally administered the formulation using an insulin syringe attached to PE10 tubing (15 mm). The tubing was inserted into one of the nares (Charlton et al., 2007) . The brains were harvested after 5min, the olfactory bulbs separated, fixed in formalin and 0.5mm thick coronal sections were prepared for microscopy.
Coherent Anti-Stokes Raman Scattering (CARS) and Two Photon Fluorescence (TPF) Microscopy
For CARS imaging, the dual wavelength picosecond excitation required was provided by an optical parametric oscillator (OPO) (Levante Emerald, APE, Berlin) pumped by a 532 nm beam generated by a frequency doubled Nd:Vanadium laser with a pulse width of 6 ps (Emerald Engine, APE, Berlin) directed into a modified commercial Olympus microscope, as described in our previous studies (Garrett et al., 2012) . The laser fundamental at 1064 nm alone was used to excite (TPF), whereas CARS was generated with the fundamental 1064 nm beam as the Stokes beam and the OPO's signal beam as the pump. Both CARS and TPF signals were detected using a photomultiplier tube (R3896, Hamamatsu, Welwyn Garden City, UK) in the epi-direction, using a 750 nm long pass dichroic (750dcxr 229 Chroma, Yokohama, Japan) and two filters centred at 660 nm (Ealing Inc., Scotts Valley, USA) to separate the signal from the laser fundamental, using a 60× 1.0NA water immersion objective lens (LUMFI, 210
Olympus) to direct the laser light to the sample. All images were acquired with an approximately 11 seconds frame rate and a frame size of 512 x 512 pixels. The combined laser power was kept below 40 mW at the sample. This power was sufficiently low enough to prevent photo damage from occurring.
The CARS signal provided structural contrast from the samples, with the pump and Stokes beams tuned to excite the CH2 stretch at 2845 cm -1 (characteristic of lipid-rich structures such as myelin sheaths and lipid droplets etc.) For TPF imaging, the naturally occurring background fluorescence from the brain was separated from the particle fluorescence by adjusting the brightness and contrast of the images. With the PMT voltages used in these experiments, the 16-bit data sets (i.e. a possible pixel intensity range of 0 -65536) exhibited a maximum intensity value of approximately 270 for the control samples, and 4079 for the samples exposed to the fluorescent particles.
Statistical Analysis
Data was analysed using Two Way ANOVA methods followed by Bonferroni post tests using Prism 4 Software. Statistical significance was set at a p value of less than 0.05.
Results
Synthesis and Structural Characterisation of Ethylamino Glycol Chitosan
A new polymer (EAGC) for nucleic acid delivery has been designed, synthesised and characterised by NMR and GPC-MALLS (Figure 1 ). The level of modification was calculated by comparing the substituted glycol chitosan C2-methines at 2.5 ppm (diethylamine) and 2.7 ppm (monoethylamine) with the other sugar protons at 3.3 -4.1 ppm.
Five different polymers were synthesised with different mole percentage levels of ethylamine substitution per GC monomer. EAGC11 has a degree of substitution of 11 mole% (i.e. 11 moles of ethylamine groups per 100 moles of GC monomer), EAGC17 has a degree of substitution of 17 mole%, EAGC21 of 21 mole%, EAGC22 of 22 mole% and EAGC29 of 29 mole% (Table 1) .
We observed the double substitution of the glycol chitosan C2 amino groups when the reaction was carried out at 40°C. This is due to the reactivity of the secondary amine once formed as secondary amines have slightly higher pKa values than primary amines; they thus behave as stronger nucleophiles (Clayden et al., 2001; Solomons and Fryhle, 2011) . The net result is the production of tertiary amines in the presence of the carbocation ethylamine electrophile.
At room temperature we did not observe the double substitution of the glycol chitosan C2 amino group and substitution levels were reduced when the reaction was carried out at room temperature (Compare EAGC29 and EAGC11 - Table 1 ). As higher molecular weight GC was used to synthesise EAGC11, EAGC22 and EAGC29, the molecular weights of these polymers are higher than the molecular weights of EAGC17 and EAGC21. It should be noted that GC17 recorded a higher molecular weight than its substituted product, EAGC17. The molecular weight determination technique records the size distribution of a large number of individual molecules and we conclude that this molecular weight difference is evidence of the resolution limit of the technique. When the reaction was carried out at 40°C, increasing the feed ratio of 2-tertbutoxycarbonylamino-ethyl bromide produced a more substituted polymer and hence manipulating the reaction stoichiometry and reaction temperature may be used to produce polymers with different levels of ethylamine substitution.
Unusually the level of secondary amine content remained at between 11.4 and 13.1 mole% for all of the polymers prepared at a GC monomer, 2-tertbutoxycarbonylamino-ethyl bromide molar feed ratio of 1: 10 or less (Table 1) , suggesting an upper limit of secondary amine modification and the increase in the overall substitution level observed was a direct result of an increase in the tertiary amine levels. This finding was consistent between the two molecular weight ranges studied (17 -18 kDa and 25 -29 kDa). It is noteworthy that when the GC monomer, 2-tertbutoxycarbonylamino-ethyl bromide molar feed ratio was 1: 40 (increasing the relative level of the amino alkyl reagent), the result was a polymer comprising only of tertiary amines (i.e. EAGC22, Table 1 ). A range of potential polymer vectors have been produced and these will be used to study the molecular variables governing the biological activity of these polymers. The potentiometric titration curves of the GC and EAGC polymers ( Figure 2 ) were based on the following chemical reaction:
HCl + GC-NR2H + + NaOH  NaCl + GC-NR2 + H2O
where R is either hydrogen or the ethylamine group. Interestingly Figure 2 shows two inflection points: the first point corresponds to the neutralization of excess hydrochloric acid and the second to the neutralization of the available amine hydrochloride groups on EAGC. It was not possible to separate out the neutralization of primary, secondary and tertiary amine hydrochloride groups, and hence calculate the correspondent pKa values, due to the heterogeneity of the polymer. Instead the buffer capacity was determined as this is relevant to the polymer's ability to buffer and then escape the acidic endosome compartment.
The volume of NaOH (0.05M) required to bring the pH from 5.1 to 7.5 in the case of EAGC11, EAGC17, EAGC21, EAGC22 and EAGC29 was higher than the volume of base required for GC17 (Table 1 ). This indicated the new polymers had a higher buffer capacity, when compared with GC17. The buffer capacity of the different types of EAGCs is defined as the percentage of amino groups that become protonated in the pH range 5.1 to 7.4. Increasing the degree of ethylamine substitution increased the buffer capacity of the EAGCs (Table 1) .
These new alkylamines, unlike the primary amines of GC (pKa = 6.41 ± 0.05) (Chooi et al., 2014) would have pKa values (Piest and Engbersen, 2010; Wang et al., 2002) , in the range of 9 -10 and consequently these new alkylamines increased the buffering capacity of the polymers. EAGC22, with only tertiary amines, had a lower buffer capacity when compared with a comparable polymer with a mixture of secondary and tertiary amines (e.g. EAGC21, Table 1 ). This is not surprising as tertiary amines usually have a lower pKa than secondary amines (Sykes, 1986 ).
Physical Characterization of EAGC -Nucleic acid Particles
Agarose gel retardation essay
Agarose gel electrophoresis was performed to investigate the binding between the EAGC polymers and plasmid DNA, mRNA and siRNA ( Figure 3 ). The complexes were allowed to interact for 30 min or 1 h before being subjected to electrophoresis. The naked nucleic acids were used as controls. GC17 was unable to condense DNA (Figure 3a and 3b ). This was due to the non-protonation of the primary amines in the glycol chitosan backbone at physiological pH, since the pKa of GC is 6.41 ± 0.05 (Chooi et al., 2014) . Non-protonated amine groups will be unable to electrostatically complex with the negatively charged plasmid DNA.
The introduction of new alkylamine moieties, which are presumably protonated at physiological pH, enabled the EAGC polymers to electrostatically bind to the anionic nucleic acids and form nanoparticles. The less substituted polymers (EAGC17 and EAGC21) were less efficient at condensing DNA than the more heavily substituted polymer (EAGC29).
EAGC17 and EAGC21 were unable to condense plasmid DNA within the 30min incubation period at polymer, DNA weight ratios of less than 20: 1 or 10: 1 respectively (Figures 3c and   3e ) and only able to condense DNA after one hour of incubation at a ratio of 10: 1 and above for EAGC17 (Figure 3d ) and at all weight ratios with EAGC21 (Figure 3f ). Increasing the degree of substitution (e.g. with EAGC29) enabled DNA condensation at polymer, DNA weight ratios of 5: 1 and above (Figure 3g and 3h) . Hence increasing the buffering capacity of GC with the addition of basic amine groups transformed GC into a DNA polyplex forming polymer.
Furthermore increasing the density of amine groups per polymer increased the DNA binding capacity of the polymers.
EAGC29 was more efficient at complexing DNA than siRNA. While DNA complexation with EAGC29 occurred at polymer, DNA weight ratios of 5 and above (Figures 3g and 3h) , complexation of EAGC29 with siRNA occurred at polymer, DNA weight ratios of 10 and above (Figures 3i and 3j ). It has been reported that siRNA -chitosan polyplexes are less stable, when compared with DNA polyplexes with chitosan (Liu et al., 2007) . The explanation given for this observation centred on the relative ease with which a longer polynucleotide chain would interact with multiple chitosan polymer chains when compared to a shorter polynucleotide chain (Liu et al., 2007) . It is our opinion that a similar phenomenon is operating with EAGC29
and DNA is thus easier to complex than siRNA. mRNA was effectively complexed by EAGC11
at all the weight ratios tested (Figure 3k ).
Transmission Electron Microscopy
Morphological characterization of the nanoparticles formed between EAGC17, EAGC21 and EAGC29 and both DNA and siRNA was performed using transmission electron microscopy (TEM, Figure 4 ). Prior to condensation, both naked DNA and naked siRNA were visible as electron dense fibres (due to the staining of the hydrophilic DNA - Figures 4a and 4e ) whereas on condensation with the polymers, electron dense 100 -400 nm spherical nanoparticles were formed (Figures 4b -d and Figure 4f ). Toroidal structures were visualised with EAGC29 -siRNA polyplexes (Figure 4f ).
The TEM data provide further evidence of polyplex formation.
Size and Zeta Potential
Polymer, nucleic acid (siRNA and DNA) complex particle size was determined by nanoparticle tracking analysis (Figures 5a and b, Table 2 ) and particles were ~ 150 -400 nm in size At the lower polymer, DNA weight ratios (1: 1, 5: 1, 10: 1 and 30: 1), EAGC17 produced slightly larger complexes than at the higher polymer, DNA weight ratios and this data correlates with certain elements of the agarose gel electrophoresis data, showing that DNA was only fully complexed by EAGC17 at a polymer, weight ratio of 10: 1 and above (Figure 3d ).
The higher the charge density on the polymers (charge density follows the trend: EAGC17 < EAGC21 < EAGC29), the fewer polymer chains that would be sufficient to form compact electrostatic complexes with the negatively charged DNA, hence more compact complexes are formed with EAGC17 and DNA at higher polymer, DNA weight ratios (40: 1, 50: 1 and 60:
1). The size of the EAGC21, DNA complexes did not change with polymer, DNA weight ratios and 200 nm complexes were formed at all polymer, DNA weight ratios (Figure 5a and 3f ).
Interestingly EAGC29, DNA complexes were significantly larger than the other polymer complexes at the higher polymer, DNA weight ratios (40: 1, 50: 1 and 60: 1). It is possible that the higher molecular weight of EAGC29 led to this observation as polymer molecular weight correlates positively with nanoparticle size . Once siRNA was fully complexed by EAGC29 (i.e. at a polymer, siRNA weight ratio equal to 10: 1 or higher - Figure   3i ), 200 nm complexes were formed with no change in complex particle size as the level of polymer in the formulation was increased. At the lower EAGC29, siRNA weight ratio of 1: 1, siRNA was not complexed with EAGC29 ( Figure 3j ) and the formulation presented with a negative zeta potential (Figure 5d ).
EAGC11, mRNA polyplexes were 150 -200 nm in size, as determined using an alternative sizing method (Malvern Zetasizer) and these were similar in size to the siRNA complexes.
Polyplexes were positively charged, which suggests effective complexation, and correlates well with the gel electrophoresis data (Figure 3k ). 
In vitro Biological Characterisation of EAGC -Nucleic acid Particles
Incubation with Heparin and Deoxyribonuclease
In the extracellular compartments, the presence of negatively charged molecules such as serum albumin and other extracellular proteins that may interact with the positively charged nanoparticles may introduce instability in the gene delivery systems (Wiethoff and Middaugh, 2002) . These anionic molecules may lead to aggregation of the nanoparticles, by charge neutralisation of the particle surface charge and lead to displacement of the nucleic acids from the delivery system due to competition (Wiethoff and Middaugh, 2002) .
The stability of the complexes in the presence of biological polyanions was thus examined by incubation with heparin ( Figure 6 ). Heparin is known to displace nucleic acids from polyplexes (Iemsam-Arng et al., 2014) . At the lower heparin concentration (0.1 mg mL -1 ) the stability of the complexes followed the trend: EAGC29 > EAGC21 > EAGC17, whereas at the higher heparin concentration (1 mg mL -1 ) the stability of the complexes followed the trend: EAGC29 > EAGC21 = EAGC17. The higher charge density of the EAGC29 polymer (a higher number of amine groups per molecule - Table 1 ) led to the creation of more stable complexes ( Figure 6 ).
A polymer, siRNA weight ratio of 60: 1 was required to resist the displacement of siRNA by heparin, when heparin was added at a concentration of 0.1 mg mL -1 (Figure 6d ), indicating that the siRNA formulations were marginally less stable than the DNA formulations ( Figure   6c ). With DNA, stable polyplexes (stable to heparin displacement, heparin concentration = 0.1 mg mL -1 ) were produced at a polymer, DNA weight ratio of 10: 1 (Figure 6c ). With 1 mg mL -1 heparin all EAGC29, siRNA complexes were destabilised (Figure 6d ). It is clear that the DNA polyplexes are more stable than the siRNA polyplexes.
One of the challenges upon administration of nucleic acids in vivo is the presence of endogenous nucleases (Alameh et al., 2012) . Deoxyribonuclease (DNAse) is an endonuclease that hydrolyses the double-stranded DNA and is one of the major barriers for gene delivery. Unprotected DNA is easily degraded by DNAse in a matter of minutes ( Figure   7a -c).
Complexes were incubated with DNAse or DNAse plus heparin; the incubation with heparin was carried out in order to observe the quality of DNA present in the complexes after incubation with DNAse. First of all EAGC, DNA formulations at a EAGC, DNA weight ratio of 60 were not sufficiently destabilised by heparin to observe the effects of DNAse on the erstwhile complexed DNA and so this particular group of formulations could not be adequately evaluated (Figure 7a-c RNase is an endonuclease that hydrolyses siRNA, completely degrading it in minutes ( Figure   7d ). In a similar manner to DNase, RNase is present in vivo in the extracellular and intracellular spaces, and is one of the major barriers for siRNA delivery (Abdelhady et al., 2003) . EAGC29
protected siRNA from RNAse degradation at all EAGC29, siRNA weight ratios.
It is clear that EAGC29, nucleic acid formulations were stable to destabilisation by anions and by nucleases.
Cell Cytotoxicity Assay
The IC50 for Lipofectamine 2000 was 0.071 mg mL -1 (Figure 8 ). All the EAGC polymers were significantly (p < 0.05) less cytotoxic than Lipofectamine 2000 with IC50 values ranging from 0.373 ± 0.054 -4.047 ± 0.30 mg mL -1 (Table 1 and Figure 8 ). EAGC11 was the least toxic polymer although it must be stated that this polymer was only incubated with the cells for 4h
and not for 6 h, due to this being the length of time EAGC11 was in contact with the cells during the transfection study. EAGC17 was significantly less cytotoxic than EAGC21 and EAGC29 (p < 0.001). All the EAGC polymers were less toxic than branched PEI (IC50 in the A431 cell line = 0.0019 mg mL -1 ) (Brownlie et al., 2004) , the diaminobutane dendrimers (IC50 in the A431 cell line = 0.039 mg mL -1 ) (Zinselmeyer et al., 2002) and linear PEI (0.074 mg mL -1 in the A431 cell line) (Kafil and Omidi, 2011) .
To examine the influence of molecular structure on cell cytotoxicity, all cytotoxicity data was treated in a similar manner, despite the differences in cell incubation times. Interestingly, Table 1 shows there is not a simple correlation between the number of amines in the polymer and toxicity. EAGC11 has more amines than both EAGC17 and EAGC21, due to its increased size, but has a higher IC50 value. However there was a negative correlation between the degree of tertiary amine substitution (DStert) and the IC50 (Figure 8b (Brownlie et al., 2004; Cheng et al., 2006) ]. When compared to existing and commercial transfection vectors, it is concluded that more biocompatible polymers have been created in our work and that these polymers are able to complex with nucleic acids and protect these nucleic acids from degradation by endonucleases and displacement by anionic biopolymers. The next test is to examine if these polymers are capable of transferring nucleic acids into cells and achieving either protein expression of an exogenous gene or protein down regulation of an endogenous gene.
Plasmid Transfection efficiency
The transfection efficiencies of the new EAGC polymers were evaluated using both DNA and siRNA. In the first instance all polymers were able to deliver plasmid DNA to the A431 cells and enable the exogenous protein (-galactosidase) to be expressed (Figure 9 ).
Lipofectamine 2000 was used as a positive control in accordance with the manufacturer's instructions and applied at a plasmid concentration of 0.1 μg per well, whereas the EAGC polyplexes were applied at a plasmid concentration of 1 μg per well. The use of higher levels of plasmid with Lipofectamine was not possible due to the cytotoxicity of the lipid.
All the polymers showed poor transfection at a polymer, DNA weight ratio of 1: 1, evidence that DNA complexation (Figure 3d , f and h) is required for transfection. EAGC21 and EAGC29
polyplexes produced significantly more protein expression when compared to EAGC17 at the 5, 10, 20 and 30 polymer, DNA weight ratio, indicating that a higher charge density on the polymers (Table 1) and thus a greater ability to complex DNA ( Figure 3 ) promoted transfection (Figure 9d ). At the polymer, DNA weight ratios above 20: 1, all the polyplexes produced protein expression that was in excess of that seen with DNA alone (Figure 9 ). At the polymer, DNA weight ratio of 60, EAGC29 was less efficient than when used at lower polymer, DNA weight ratios (Figure 9c ). This polymer was the most cytotoxic of the three polymers used (Table 1) and at an EAGC29, polymer weight ratio of 60: 1 and when adding 1 μg DNA per well, the concentration of EAGC29 used would be 0.6 mg mL -1 , which is very close to the IC50 of EAGC29 (0.523 ± 0.17 mg mL -1 , Table 1 ). It is thus possible that this cytotoxicity reduced the observed protein expression. Peak transfection activity was observed with EAGC17, EAGC21 and EAGC29 at polymer, DNA weight ratios of 60: 1, 30: 1 and 30: 1 respectively.
It is clear that an increase in the density of amines per polymer molecule promotes gene complexation, and thus gene transfer into cells but that the density of amines requires to be controlled so as not to produce a polymer formulation that is inherently cytotoxic.
Effect of Chloroquine
We sought to determine if the transfection efficiency of a representative EAGC polymer (EAGC21) would be improved in the presence of chloroquine. Chloroquine increases the pH of the endosome (Murphy et al., 1984) and in turn increases the transfection efficiency of polymers, not only by buffering the endosome but also by possibly dissociating the polymers from the nucleic acids (Erbacher et al., 1996) . The application of chloroquine did not improve the transfection efficiency (Figure 9e ) of the EAGC polymer or of Lipofectamine 2000 but actually decreased protein expression at the lower polymer, DNA weight ratios. It is conceivable that at low polymer, DNA weight ratios, chloroquine could have resulted in the premature displacement of the nucleic acid from the polyplexes, thus resulting in reduced protein expression. However the results are by no means conclusive and further in depth examination of the effect of chloroquine is warranted.
Presence of proteins
We then set out to examine the effect of proteins on the transfection efficiency of the polymers, using EAGC21 as a representative polymer. Serum proteins are known to destabilise polyplexes (Iemsam-Arng et al., 2014) .
There was minimal impact on transfection from the presence of proteins in the media ( Figure   9f ), with only the EAGC21 polyplexes showing a decrease in transfection efficiency at a polymer, DNA weight ratio of 30 in the presence of protein and a slight increase in transfection efficacy observed at a polymer, DNA weight ratio of 50 in the presence of proteins. As the changes in transfection efficacy were, in essence, a 25% drop in protein expression (at a polymer, DNA weight ratio of 30) and a 20% increase in protein expression (at a polymer, DNA weight ratio of 50: 1), we conclude that proteins have a minimal effect on the in vitro transfection efficacy of the EAGC21 polymer and that the level of protein used in our in vitro experiments did not lead to any material changes in target protein expression. Others have reported that serum does not lead to a change in protein expression with chitosan based delivery systems also (Erbacher et al., 1998; Mao et al., 2001 ). Figure 10 demonstrates that EAGC22 was able to transfer mRNA into cells, which then was translated into functional protein. Polyplexes with EAGC22 at polymer : mRNA weight ratio 70:1 showed highest transfection efficiency. The transfection efficiency of EAGC22 was comparable to that shown by the commercial transfection -reagent JetPEI.
mRNA Delivery
siRNA Gene Silencing Efficiency
We then sought to examine the ability of the most substituted polymer (EAGC29) to deliver siRNA to A431 cells. Anti-ITCH siRNA (de la Fuente et al., 2015) was used in these studies.
ITCH is an ubiquitin ligase that is involved in controlling cell growth, differentiation and apoptotic process. Its targets are transcription factors and growth factor receptors that act as gene expression regulators (Melino et al., 2008) . The data in Figure 11 show increasing levels of ITCH gene knock down with increasing polymer, siRNA weight ratios. The knockdown observed is specific for the ITCH gene as the control samples (Scrambled siRNA) do not show any gene silencing.
In vivo siRNA Delivery
The aim of our work is to produce biocompatible nucleic acid transfer systems that may be used via the nose to brain route to achieve brain gene silencing. Hence a preliminary nose to brain delivery study was carried out in a healthy rat model in order to see if intact siRNA could be delivered to neuronal cells. Figure 12 shows the CARS images of ex-vivo brain samples from representative animals in groups of treated and untreated mice. Untreated animals show no sign of siRNA fluorescence (Figure 12a ). 5 minutes after administration of the EAGC29, siRNA (polymer, siRNA ratio = 60: 1) formulation, siRNA fluorescence was seen in the olfactory bulb ( Figure 12c ) and the signal was 12 times higher when compared to the signal seen in the olfactory bulbs from animals that had been dosed with siRNA alone (Figure 12b ). These images demonstrate that nasal delivery to the olfactory bulb was achieved with fluorescent siRNA EAGC29
formulations. These preliminary results introduce EAGC29 as a good candidate for subsequent in vivo studies of siRNA delivery to the brain. To establish these delivery systems as suitable nose to brain vectors, further work will need to address the biodistribution of the nanoparticles to the different tissues of the brain as well as the pharmacological activity of the systems.
Discussion
The absence of biocompatible delivery systems continues to be the single reason why gene therapy has yielded only a handful of registered products (Miller, 2012; Peng, 2005) . Despite considerable investment (Ledley et al., 2014) gene therapy either in the form of RNA or DNA actives has not fulfilled its potential. Our aim is to prepare biocompatible nucleic acid delivery systems that may be used to achieve nose to brain gene silencing and we hypothesise that by limiting the density of the amine moieties on a polymeric delivery system, we would produce an efficient delivery system with minimal cell cytotoxicity. There is evidence from the diaminobutane dendrimer series that a larger number of amines per molecule (a higher molecular weight) is correlated with increasing cytotoxicity (Zinselmeyer et al., 2002) and that primary amine polymers are more toxic than polymers containing carboxylate surface groups (Malik et al., 2000) . Furthermore functionalising PEI primary amines with poly(ethylene glycol), quaternary ammonium or palmitoyl moieties also led to a reduction in PEI cell cytotoxicity (Brownlie et al., 2004) . However these structural modifications also led to a reduction in transfection efficiency (Brownlie et al., 2004) . Clearly it is important to control the number of amine groups, as amine groups are essential for synthetic vector gene transfer, but
we also need to ensure that we do not produce polymer vectors with unacceptable cell GC contains amine groups with a low pKa of 6.41 ± 0.05 (Chooi et al., 2014) and hence these GC amines will not be protonated at physiological pH (have a low buffering capacity - Table   1 , Figure 2 ) and are unable to complex with DNA (Figure 3a and b) . Adding the new alkylamine moieties to GC to produce EAGC, resulted in polymers with a higher buffering capacity (indicative of a higher pKa - Table 1 , Figure 2 ) and endowed these polymers with the ability to condense nucleic acids (Table 2, ( Figure 8 ) and both linear (Kafil and Omidi, 2011) and branched (Brownlie et al., 2004; Cheng et al., 2006) PEI. This is important, as linear PEI has been locally administered to patients in clinical trials (Gofrit et al., 2014) .
Surprisingly we found that the cytotoxicity (IC50) of these new polymers was inversely correlated with the density of the tertiary amine groups (Equation 1). These findings of a mathematical relationship between cytotoxicity and polymer structure open up the possibility that polymers with a desired biocompatibility profile may be dialed up in the future.
Our work shows that high pKa primary and secondary amines appear to be important for nucleic acid polyplex formation and cell transfer whereas tertiary amines are detrimental to the cell transfer process due to their correlation with cell cytotoxicity. It is envisaged that these polyplexes would enter the cell by endocytosis as has been reported for other polyplexes (Akinc and Langer, 2002) and as such the increased buffering capacity of the more substituted polymer (EAGC29) should enable this polymer to escape the acidic endosome, in accordance with the proton sponge hypothesis, although it must be stated that the hypothesis itself has been called into question by the observation that poly(ethylenimine), for example, does not raise lysosomal pH (Benjaminsen et al., 2013) .
When comparing polymers of similar molecular weight: EAGC17 (Mw = 16.9 kDa) and EAGC21 (17.6 kDa), it is clear that an increase in the density of ethylamine groups produces a polymer that has a higher buffer capacity (Table 1 , Figure 2 ), is more efficient at complexing DNA (Figure 3e -3i ) and forming stable complexes, which resists degradation by polyanions (Figure 6a and b) and nucleases (Figure 7a and b) . These attributes also lead to improved gene transfer (Figure 9d ). It is not clear that increasing both the molecular weight and the level of ethylamine groups, as in EAGC29, actually leads to an improved DNA vector ( Figure   9d ), despite the fact that EAGC29 is most efficient at protecting DNA from nuclease degradation ( Figure 7 ).
We can conclude that substituting GC with 20mole% ethylamine groups, limiting the level of tertiary amines and with the polymer having a final molecular weight of 17 kDa are ideal parameters for gene transfer. Previously we have reported that a degree of polymerization (DP) of 86 in other glycol chitosan derivatives was the ideal molecular weight for gene delivery in vivo, i.e. a molecular weight of approximately 18 -20 kDa ) and hence the current data is in agreement with previous findings. There has been much debate in the literature on the ideal molecular weight to use for nucleic acid delivery with chitosan and its derivatives, with some reports advocating a high molecular weight of 100 -400 kDa (Delgado et al., 2013; Huang et al., 2005; Ishii et al., 2001; MacLaughlin et al., 1998; Mao et al., 2001) and others advocating the use of chitosans with a molecular weight of less than 100 kDa (Erbacher et al., 1998; Hoggard-Koping et al., 2001; Holzerny et al., 2012; Jorgensen et al., 2012; Lee et al., 2001; Strand et al., 2010; Techaarpornkul et al., 2010) . Our data consistently
show that chitosan derivatives with molecular weights of less than 30 kDa have the right balance of cytotoxicity and nucleic acid complexation, protection and transduction activity (Figure 9d ). The fact that the lower molecular weight glycol chitosan derivatives are efficient gene transfer agents is pertinent, as high molecular weight chitosans are correlated with cytotoxicity, e.g. chitosans of high molecular weight (100 kDa) and with a high degree of deacetylation (Huang et al., 2004) were less biocompatible than low molecular weight chitosans (10 kDa) (Huang et al., 2004; Lavertu et al., 2006; Nimesh et al., 2010; Richardson et al., 1999) .
For siRNA delivery we chose the 28 kDa polymer -EAGC29, as others have reported that siRNA complexation is promoted by a higher molecular weight and higher charge density (Liu et al., 2007; Wagner, 2011) . Additionally EAGC29 produced DNA complexes that were most stable to challenge by an endogenous polyanion -heparin (Figure 6a -c) and challenge by deoxyribonuclease (Figure 7a -c) . Incidentally EAGC29, siRNA polyplexes were indeed less stable than EAGC29, DNA polyplexes when incubated with heparin ( Figure 6c and d) or deoxyribonuclease (Figure 7c and d) . However transfection competent siRNA polyplexes were produced with EAGC29 ( Figure 11 ).
One notable drawback of these polymers is the need for really high levels of polymer in the formulation. For example the generation 2 diaminobutane dendrimer are transfection competent at a dendrimer, DNA weight ratio of 5: 1 (Dufes et al., 2005; Zinselmeyer et al., 2002) whereas transfection competence peaks with EAGC29 and EAGC21 at a polymer, DNA weight ratio of 30: 1 ( Figure 9 ). However when considering the comparable IC50 values of EAGC21, EAGC29 (Table 1) The in vivo administration of nucleic acids to the brain is limited by the blood brain barrier and the intranasal route of administration is a non-invasive method of bypassing the blood brain barrier (Chapman et al., 2013; Uchegbu et al., 2014b) . These low cytotoxicity polymers that are able to complex and transfer nucleic acids into living cells were also able to locate siRNA within the olfactory bulb neurons 5 minutes after intranasal administration ( Figure 12 ). This data provides a platform for the development of biocompatible nose to brain gene and RNA therapeutics and further proves the hypothesis that a critical level of alkylamine moieties on a polymer is able to yield a polymer with low cytotoxicity but sufficient gene transfer ability.
Conclusion
In conclusion, we have prepared new chitosan derivatives that are orders of magnitude less cytotoxic than the commercial in vitro transfection reagents and clinical stage polymers and yet are able to transfer a variety of nucleic acids into cells to achieve either protein expression or gene silencing that is comparable to that achieved by the commercial reagent Lipofectamine 2000 or JetPEI. The relatively low cytotoxicity of these new polymers is crucial in that this will allow developers to produce nose to brain nucleic acid therapies for neurological indications.
An important finding from our work is that it is crucial to limit the level of tertiary amines in a polymer nucleic acid vector, as tertiary amines are strong drivers of cell cytotoxicity.
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